Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.39
-0.04 (-0.90%)
At close: Aug 15, 2025, 2:35 PM

Vanda Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
102.32M 135.82M 135.03M 52.07M
Short-Term Investments
272.33M 252.44M 331.83M 380.74M
Long-Term Investments
n/a n/a 469K 519K
Other Long-Term Assets
9.1M 9.98M 10.91M 7.63M
Receivables
47.1M 34.16M 33.51M 32.47M
Inventory
1.73M 1.36M 1.19M 1.02M
Other Current Assets
15.42M 9.17M 17.73M 12M
Total Current Assets
438.89M 432.95M 519.29M 478.3M
Property-Plant & Equipment
12.68M 9.14M 10.97M 12.38M
Goodwill & Intangibles
114.1M 121.37M 18.57M 20.08M
Total Long-Term Assets
217.31M 215.49M 114.95M 115.49M
Total Assets
656.2M 648.44M 634.25M 593.79M
Account Payables
3.5M 7.14M 12.69M 925K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
69.36M 69.33M 64.6M 58.8M
Total Current Liabilities
99.98M 87.7M 91.44M 74.42M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
9.59M 8.83M 6.8M 4.39M
Total Long-Term Liabilities
17.68M 15.83M 15.61M 14.45M
Total Liabilities
117.66M 103.53M 107.05M 88.86M
Total Debt
12.36M 9.4M 11.14M 10.05M
Common Stock
58K 58K 57K 56K
Retained Earnings
-174.29M -155.39M -157.9M -164.18M
Comprehensive Income
74K -30K -1.19M -175K
Shareholders Equity
538.55M 544.91M 527.2M 504.93M
Total Investments
272.33M 252.44M 331.83M 380.74M